Galmed Pharmaceuticals (GPH.F) Q2 2025 Earnings

2AprConfirmed
Q2 2024
Q3 2024
Q4 2024
Q2 2025
-1.78
-1.45
-1.11
-0.78

Details

Expected EPS
N/A
Actual EPS
-1.7786696
Surprise EPS
-1.78
Surprise Percent
+∞%

Description

Galmed Pharmaceuticals (GPH.F) has reported earnings of -1.7786696 per share for Q2 2025.

0 Comments

Share your thoughts